Kouta Iida

9PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyOncology and carcinogenesis not elsewhere classifiedSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 20, 2026
Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC.

|Feb 27, 2026
Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low- and Intermediate-Risk Localized Prostate Cancer.

Kota Iida, Yuriko Hayashi, Kosuke Narita

|Mar 05, 2025
Real-World Analysis of the Enfortumab Vedotin-Ineligible criTeriA Assessment in Treatment-Naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma.

Makito Miyake, Nobutaka Nishimura, Yuki Oda

|Sep 05, 2023
Composite pheochromocytoma associated with neurofibromatosis type 1.

Akira Tachibana, Kota Iida, Yoshitaka Itami

|Feb 15, 2023
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.

Tatsuki Miyamoto, Makito Miyake, Tomonori Nakahama

|Nov 30, 2022
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis.

Ryoma Nishikawa, Makito Miyake, Shuichi Morizane

Pageof 2

Frequent Collaborators

7 joint publications

Makito Miyake

6 joint publications

Kiyohide Fujimoto

3 joint publications

Takashi Kobayashi

2 joint publications

Tatsuki Miyamoto